Patient Guide: A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 10 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06953323
Status: 🟢 Enrolling Now
Condition: Advanced Solid Tumor
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 10 locations across the country.

Top locations include:
  • • Beijing, Beijing
  • • Fuzhou, Fujian
  • • Guangzhou, Guangdong
  • • And 7 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors - Join Clinical Trial NCTNCT06953323

How to Join This Clinical Trial - NCTNCT06953323

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Advanced Solid Tumor. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Advanced Solid Tumor. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Advanced Solid Tumor
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06953323 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 10 locations. Find a study site near you:

Clinical Research Site

Beijing, Beijing 100021 - China

Status: RECRUITING

Clinical Research Site

Fuzhou, Fujian 350000 - China

Status: RECRUITING

Clinical Research Site

Guangzhou, Guangdong 510000 - China

Status: RECRUITING

Clinical Research Site

Nanning, Guangxi 530000 - China

Status: RECRUITING

Clinical Research Site

Guangzhou, Gunagdong 510000 - China

Status: RECRUITING

Clinical Research Site

Wuhan, Hubei 430023 - China

Status: RECRUITING

Clinical Research Site

Changsha, Hunan 410000 - China

Status: RECRUITING

Clinical Research Site

Shenyang, Liaoning 110000 - China

Status: RECRUITING

Clinical Research Site

Shenyang, Liaoning 110001 - China

Status: ENROLLING_BY_INVITATION

Clinical Research Site

Hangzhou, Zhejiang 310000 - China

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Advanced Solid Tumor:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships